About

Founded

2020

Headquarters

La Jolla, California

Industry

Healthcare, Biotech

Company Description

Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.

Quick Links

Website Jobs

Funding

Total Raised

$2 billion

Valuation

Undisclosed

Significant Investors

New Enterprise Associates, ARCH Venture Partners, 8VC

Company Traction

As of June 2023, Resilience has 11 sites and 1 million square feet of manufacturing space.

As of February 2023, Resilience has 50+ customers.

Leadership Team

Rahul Singhvi: Co-Founder and CEO at Resilience. Former President at Ring Therapeutics.

Sandy Mahatme: President, COO, and CFO at Resilience. Former CFO and Chief Business Officer at Sarepta Therapeutics.

Syed Husain: Chief Commercial Officer at Resilience. Former SVP & Head of CDMO Business Unit at Emergent BioSolutions.

Spencer Fisk: CTO at Resilience. Former SVP and Chief Technical Operations Officer at Rubius Therapeutics.

Mara Strandlund: Chief People Officer at Resilience. Former Global HR Leader, AWS International at AWS.

Press

Fierce Pharma (March 28, 2023): As US plots biomanufacturing boost, National Resilience nets $410M loan from Defense Department

Fierce Pharma (February 22, 2023): As Sanofi contract wind-down prompts layoffs in Boston, Resilience is hiring elsewhere: CEO

TechCrunch (November 23, 2020): Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

Resilience